Showing results (1051-1060 of 1,538) with videos related to

Sort By:
Pageof 154
Clinical Genitourinary Cancer|January 20, 2016
Everolimus Versus Temsirolimus in Metastatic Renal Cell Carcinoma After Progression With Previous Systemic TherapiesShiven B Patel, David D Stenehjem, David M Gill, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2017
Prevention of chemotherapy toxicity by agents that neutralize or degrade cell-free chromatinI Mittra, K Pal, N Pancholi, et al.
Future Oncology (London, England)|February 26, 2025
STELLAR-304: a phase III study of zanzalintinib (XL092) plus nivolumab in advanced non-clear cell renal cell carcinomaSumanta K Pal, Thomas Powles, Ravindran Kanesvaran, et al.
Cancer|October 12, 2016
A phase 2 study of the sphingosine-1-phosphate antibody sonepcizumab in patients with metastatic renal cell carcinomaSumanta K Pal, Harry A Drabkin, James A Reeves, et al.
Oncotarget|January 19, 2017
Vitamin K epoxide reductase regulation of androgen receptor activityBen Yi Tew, Teresa B Hong, Maya Otto-Duessel, et al.
Clinical Genitourinary Cancer|September 12, 2022
Temporal Characteristics of Adverse Events of Tivozanib and Sorafenib in Previously Treated Kidney CancerZeynep B Zengin, Sumanta K Pal, David F McDermott, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2016
Survival Analyses of Patients With Metastatic Renal Cancer Treated With Targeted Therapy With or Without Cytoreductive Nephrectomy: A National Cancer Data Base StudyNawar Hanna, Maxine Sun, Christian P Meyer, et al.
Inorganic Chemistry|August 1, 2024
A Mononuclear [PtCl(tpy)]PF<sub>6</sub> Complex for a Yellow Emitting Solution-Processable Organic Light Emitting DiodeAbhishek Kumar Gupta, Rahat Gupta, Hannah C Potter, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 5, 2002
[18F]-Dopa positron emission tomography imaging in early-stage, non-parkin juvenile parkinsonismPramod K Pal, Joanne Leung, Katya Hedrich, et al.
Japanese Journal of Clinical Oncology|February 22, 2020
Association between PD-L1 status and immune checkpoint inhibitor response in advanced malignancies: a systematic review and meta-analysis of overall survival dataChristopher J D Wallis, Keith Lawson, Mohit Butaney, et al.
Pageof 154